The FDA has approved PT-141 for premenopausal women with HSDD, solidifying its place as a legitimate and effective medical treatment
Cardiovascular gains and sustained weight loss justify use for most, yet affordability looms: high costs strain patients, taxpayers, and governments, especially if surgery-eligible patients stall bariatric options
The science behind Mounjaro Mounjaros active ingredient is tirzepatide, which mimics GLP-1 and GIP two hormones naturally found in your intestines
Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus
Ipamorelin vs GHRP-2 vs GHRP-6: Within the Secretagogue Class Ipamorelin is frequently compared to GHRP-2 and GHRP-6 the other growth hormone secretagogues available from PSPeptides
doi: 10.3390/polym15010006